Does Breast Cancer Increasingly Affect Younger Women?


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
07 07 2020
Historique:
received: 18 05 2020
revised: 03 07 2020
accepted: 03 07 2020
entrez: 11 7 2020
pubmed: 11 7 2020
medline: 2 10 2020
Statut: epublish

Résumé

Breast cancer is the most frequently diagnosed malignant neoplasm among females. The proportion of women diagnosed in the premenopausal period is relatively small. Nevertheless, this is the most commonly diagnosed cancer among young women. The aim of the study was to analyze the incidence rate of breast cancer in a group of young women based on data obtained in the Lower Silesian Voivodeship between 1984 and 2016. A total of 34,251 women with a diagnosis of invasive breast cancer were analyzed. The median age of diagnosis exhibited an upward trend from 57 to 63. The youngest age of breast cancer diagnosis did not decrease. Women up to the age of 24 were sporadically diagnosed. Given the total number of cases, the proportion of women under the age of 39 was approximately 5%, and it did not increase throughout the entire examination period. The major increase in the growth trend during the analyzed period was observed in a group of women aged of 50-69 (regression coefficient: +24.9) and above 70 (regression coefficient +21.2). In a group of women under 40 the regression coefficient was only +4. It seems that breast cancer does not increasingly affect younger women since the risk in this age group remains low. However, an increasing incidence rate of breast cancer is more commonly observed in premenopausal women.

Identifiants

pubmed: 32645841
pii: ijerph17134884
doi: 10.3390/ijerph17134884
pmc: PMC7370185
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Natl Cancer Inst. 2008 Nov 19;100(22):1643-8
pubmed: 19001605
CMAJ. 2019 Nov 18;191(46):E1262-E1273
pubmed: 31740536
J Clin Oncol. 2003 Nov 15;21(22):4184-93
pubmed: 14615446
Breast Cancer Res. 2016 Aug 04;18(1):79
pubmed: 27492244
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Br J Cancer. 2007 Jun 4;96(11):1743-6
pubmed: 17533391
J Natl Cancer Inst. 2013 Jul 3;105(13):978-88
pubmed: 23723422
CA Cancer J Clin. 2019 Nov;69(6):438-451
pubmed: 31577379
Eur J Obstet Gynecol Reprod Biol. 2011 Jul;157(1):89-93
pubmed: 21439713
J Clin Oncol. 2008 Jul 10;26(20):3324-30
pubmed: 18612148
Radiology. 2011 Jan;258(1):98-105
pubmed: 21081671
J Natl Cancer Inst. 2009 Nov 18;101(22):1584-91
pubmed: 19861303
J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8
pubmed: 23819024
Cancer. 2018 Sep 1;124(17):3500-3509
pubmed: 30189117
Eur J Cancer. 2007 Sep;43(13):1905-17
pubmed: 17681781
Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1214-1222
pubmed: 30068516
J Natl Cancer Inst. 2019 Dec 1;111(12):1279-1297
pubmed: 31145458
Ann Oncol. 2020 Mar 19;:
pubmed: 32199930
Radiother Oncol. 2007 Mar;82(3):272-80
pubmed: 17287037
AJR Am J Roentgenol. 2003 Apr;180(4):935-40
pubmed: 12646432
Breast Cancer Res Treat. 2013 Feb;138(1):241-8
pubmed: 23371505
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:208-211
pubmed: 29804884
J Natl Cancer Inst. 2010 May 19;102(10):692-701
pubmed: 20439838
BMJ. 2011 Jul 28;343:d4411
pubmed: 21798968
Lancet. 2005 Dec 17;366(9503):2087-106
pubmed: 16360786
Cancer Epidemiol. 2013 Oct;37(5):544-9
pubmed: 23768969
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Breast Cancer Res Treat. 2018 Jun;169(3):595-606
pubmed: 29445940
Breast Cancer Res. 2010;12(5):212
pubmed: 21067532
Breast Cancer Res Treat. 2012 Jul;134(1):363-70
pubmed: 22456983
Breast. 2019 Oct;47:85-92
pubmed: 31362134
Breast. 2015 Apr;24(2):112-7
pubmed: 25522906
BMC Cancer. 2018 Aug 2;18(1):781
pubmed: 30068302

Auteurs

Katarzyna Konat-Bąska (K)

Katedra Onkologii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu (Department of Oncology, Wroclaw Medical University), 53-413 Wrocław, Poland.
Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Rafał Matkowski (R)

Katedra Onkologii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu (Department of Oncology, Wroclaw Medical University), 53-413 Wrocław, Poland.
Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Jerzy Błaszczyk (J)

Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Dawid Błaszczyk (D)

Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Urszula Staszek-Szewczyk (U)

Katedra Onkologii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu (Department of Oncology, Wroclaw Medical University), 53-413 Wrocław, Poland.
Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Natalia Piłat-Norkowska (N)

Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Adam Maciejczyk (A)

Katedra Onkologii, Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu (Department of Oncology, Wroclaw Medical University), 53-413 Wrocław, Poland.
Dolnośląskie Centrum Onkologii we Wrocławiu (Wroclaw Comprehensive Cancer Center), 53-413 Wroclaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH